{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:44:58Z","timestamp":1782773098551,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01432-9","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:07:15Z","timestamp":1782101235000},"page":"823-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acquisition of Vimentin by trogocytosis inhibits the NK cell-mediated immune response against circulating tumour cells (CTCs)"],"prefix":"10.1038","volume":"23","author":[{"given":"Lu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-1417","authenticated-orcid":false,"given":"Hai-Long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ji","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"1432_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.it.2018.12.003","volume":"40","author":"F Souza-Fonseca-Guimaraes","year":"2019","unstructured":"Souza-Fonseca-Guimaraes F, Cursons J, Huntington ND. The emergence of natural killer cells as a major target in cancer immunotherapy. Trends Immunol. 2019;40:142\u201358.","journal-title":"Trends Immunol"},{"key":"1432_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","volume":"31","author":"EO Long","year":"2013","unstructured":"Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013;31:227\u201358.","journal-title":"Annu Rev Immunol"},{"key":"1432_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","volume":"19","author":"KL O\u2019Brien","year":"2019","unstructured":"O\u2019Brien KL, Finlay DK. Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019;19:282\u201390.","journal-title":"Nat Rev Immunol"},{"key":"1432_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","volume":"23","author":"AT Ruffin","year":"2023","unstructured":"Ruffin AT, Li H, Vujanovic L, Zandberg DP, Ferris RL, Bruno TC. Improving head and neck cancer therapies by immunomodulation of the tumor microenvironment. Nat Rev Cancer. 2023;23:173\u201388.","journal-title":"Nat Rev Cancer"},{"key":"1432_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","volume":"32","author":"A L\u00f3pez-Soto","year":"2017","unstructured":"L\u00f3pez-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of metastasis by NK cells. Cancer Cell. 2017;32:135\u201354.","journal-title":"Cancer Cell"},{"key":"1432_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.smim.2017.08.002","volume":"31","author":"KJ Malmberg","year":"2017","unstructured":"Malmberg KJ, Carlsten M, Bj\u00f6rklund A, Sohlberg E, Bryceson YT, Ljunggren HG. Natural killer cell-mediated immunosurveillance of human cancer. Semin Immunol. 2017;31:20\u201329.","journal-title":"Semin Immunol"},{"key":"1432_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-025-03375-x","volume":"44","author":"D Masmoudi","year":"2025","unstructured":"Masmoudi D, Villalba M, Alix-Panabi\u00e8res C. Natural killer cells: the immune frontline against circulating tumor cells. J Exp Clin Cancer Res. 2025;44:118.","journal-title":"J Exp Clin Cancer Res"},{"key":"1432_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1158\/2326-6066.CIR-16-0152","volume":"5","author":"L Peng","year":"2017","unstructured":"Peng L, Zhang J, Teng Y, Zhao Y, Wang T, Mao F, et al. Tumor-associated monocytes\/macrophages impair NK-cell function via TGF\u03b21 in human gastric cancer. Cancer Immunol Res. 2017;5:248\u201356.","journal-title":"Cancer Immunol Res"},{"key":"1432_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2017.00760","volume":"8","author":"J Bi","year":"2017","unstructured":"Bi J, Tian Z. NK cell exhaustion. Front Immunol. 2017;8:760.","journal-title":"Front Immunol"},{"key":"1432_CR10","doi-asserted-by":"publisher","first-page":"681615","DOI":"10.3389\/fimmu.2021.681615","volume":"12","author":"A Ziblat","year":"2021","unstructured":"Ziblat A, Iraolagoitia XLR, Nu\u00f1ez SY, Torres NI, Secchiari F, Sierra JM, et al. Circulating and tumor-infiltrating NK cells from clear cell renal cell carcinoma patients exhibit a predominantly inhibitory phenotype characterized by overexpression of CD85j, CD45, CD48 and PD-1. Front Immunol. 2021;12:681615.","journal-title":"Front Immunol"},{"key":"1432_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41423-019-0224-2","volume":"16","author":"G Habif","year":"2019","unstructured":"Habif G, Crinier A, Andr\u00e9 P, Vivier E, Narni-Mancinelli E. Targeting natural killer cells in solid tumors. Cell Mol Immunol. 2019;16:415\u201322.","journal-title":"Cell Mol Immunol"},{"key":"1432_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/2326-6066.CIR-18-0085","volume":"7","author":"A Frazao","year":"2019","unstructured":"Frazao A, Messaoudene M, Nunez N, Dulphy N, Roussin F, Sedlik C, et al. CD16(+)NKG2A(high) natural killer cells infiltrate breast cancer-draining lymph nodes. Cancer Immunol Res. 2019;7:208\u201318.","journal-title":"Cancer Immunol Res"},{"key":"1432_CR13","doi-asserted-by":"publisher","first-page":"e005061","DOI":"10.1136\/jitc-2022-005061","volume":"10","author":"C Lou","year":"2022","unstructured":"Lou C, Wu K, Shi J, Dai Z, Xu Q. N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor. J Immunother Cancer. 2022;10:e005061.","journal-title":"J Immunother Cancer"},{"key":"1432_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4248\/IJOS10006","volume":"2","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Helman JI, Li L. Lymphangiogenesis, lymphatic endothelial cells and lymphatic metastasis in head and neck cancer\u2013a review of mechanisms. Int J Oral Sci. 2010;2:5\u201314.","journal-title":"Int J Oral Sci"},{"key":"1432_CR15","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1158\/0008-5472.CAN-22-1902","volume":"82","author":"IE Elkholi","year":"2022","unstructured":"Elkholi IE, Lalonde A, Park M, C\u00f4t\u00e9 JF. Breast cancer metastatic dormancy and relapse: an enigma of microenvironment(s). Cancer Res. 2022;82:4497\u2013510.","journal-title":"Cancer Res"},{"key":"1432_CR16","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.4049\/jimmunol.168.12.6208","volume":"168","author":"M Faure","year":"2002","unstructured":"Faure M, Long EO. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol. 2002;168:6208\u201314.","journal-title":"J Immunol"},{"key":"1432_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/ni0903-815","volume":"4","author":"E Joly","year":"2003","unstructured":"Joly E, Hudrisier D. What is trogocytosis and what is its purpose? Nat Immunol. 2003;4:815.","journal-title":"Nat Immunol"},{"key":"1432_CR18","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3390\/ijms22052236","volume":"22","author":"KJ Li","year":"2021","unstructured":"Li KJ, Wu CH, Lu CH, Shen CY, Kuo YM, Tsai CY, et al. Trogocytosis between non-immune cells for cell clearance, and among immune-related cells for modulating immune responses and autoimmunity. Int J Mol Sci. 2021;22:2236.","journal-title":"Int J Mol Sci"},{"key":"1432_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3390\/cells10051255","volume":"10","author":"K Miyake","year":"2021","unstructured":"Miyake K, Karasuyama H. The role of trogocytosis in the modulation of immune cell functions. Cells. 2021;10:1255.","journal-title":"Cells"},{"key":"1432_CR20","doi-asserted-by":"publisher","first-page":"102331","DOI":"10.1016\/j.coi.2023.102331","volume":"83","author":"P Schriek","year":"2023","unstructured":"Schriek P, Villadangos JA. Trogocytosis and cross-dressing in antigen presentation. Curr Opin Immunol. 2023;83:102331.","journal-title":"Curr Opin Immunol"},{"key":"1432_CR21","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1128\/IAI.00930-19","volume":"88","author":"A Bettadapur","year":"2020","unstructured":"Bettadapur A, Miller HW, Ralston KS. Biting off what can be chewed: trogocytosis in health, infection, and disease. Infect Immun. 2020;88:e919\u201330.","journal-title":"Infect Immun"},{"key":"1432_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01894-9","volume":"22","author":"F Ramezani","year":"2023","unstructured":"Ramezani F, Panahi Meymandi AR, Akbari B, Tamtaji OR, Mirzaei H, Brown CE, et al. Outsmarting trogocytosis to boost CAR NK\/T-cell therapy. Mol Cancer. 2023;22:183.","journal-title":"Mol Cancer"},{"key":"1432_CR23","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1126\/sciadv.abj3286","volume":"8","author":"MS Hasim","year":"2022","unstructured":"Hasim MS, Marotel M, Hodgins JJ, Vulpis E, Makinson OJ, Asif S, et al. When killers become thieves: trogocytosed PD-1 inhibits NK cells in cancer. Sci Adv. 2022;8:3286.","journal-title":"Sci Adv"},{"key":"1432_CR24","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1073\/pnas.1300140110","volume":"110","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Nakayama M, Kawano M, Amagai R, Ishii T, Harigae H, et al. Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand. Proc Natl Acad Sci USA. 2013;110:9421\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1432_CR25","doi-asserted-by":"publisher","first-page":"791006","DOI":"10.3389\/fimmu.2022.791006","volume":"13","author":"S Zhao","year":"2022","unstructured":"Zhao S, Zhang L, Xiang S, Hu Y, Wu Z, Shen J. Gnawing between cells and cells in the immune system: friend or foe? A review of trogocytosis. Front Immunol. 2022;13:791006.","journal-title":"Front Immunol"},{"key":"1432_CR26","doi-asserted-by":"publisher","first-page":"11258","DOI":"10.1073\/pnas.0600721103","volume":"103","author":"P Roda-Navarro","year":"2006","unstructured":"Roda-Navarro P, Vales-Gomez M, Chisholm SE, Reyburn HT. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function. Proc Natl Acad Sci USA. 2006;103:11258\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1432_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-05912-0","volume":"616","author":"S Sen Santara","year":"2023","unstructured":"Sen Santara S, Lee DJ, Crespo \u00c2, Hu JJ, Walker C, Ma X, et al. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature. 2023;616:348\u201356.","journal-title":"Nature"},{"key":"1432_CR28","doi-asserted-by":"publisher","first-page":"14477","DOI":"10.1021\/bi051241s","volume":"44","author":"A Zilka","year":"2005","unstructured":"Zilka A, Landau G, Hershkovitz O, Bloushtain N, Bar-Ilan A, Benchetrit F, et al. Characterization of the heparin\/heparan sulfate binding site of the natural cytotoxicity receptor NKp46. Biochemistry. 2005;44:14477\u201385.","journal-title":"Biochemistry"},{"key":"1432_CR29","doi-asserted-by":"crossref","unstructured":"Winkelaar G, Trieber C, Kumar J, Overduin M. Measuring interactions of globular and filamentous proteins by nuclear magnetic resonance spectroscopy (NMR) and microscale thermophoresis (MST). J Vis Exp. 2018;141:10\u20133791.","DOI":"10.3791\/58537-v"},{"key":"1432_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cbic.200600413","volume":"8","author":"E Duchardt","year":"2007","unstructured":"Duchardt E, Sigalov AB, Aivazian D, Stern LJ, Schwalbe H. Structure induction of the T-cell receptor zeta-chain upon lipid binding investigated by NMR spectroscopy. Chembiochem Eur J Chem Biol. 2007;8:820\u20137.","journal-title":"Chembiochem Eur J Chem Biol"},{"key":"1432_CR31","doi-asserted-by":"publisher","first-page":"104859","DOI":"10.1016\/j.critrevonc.2025.104859","volume":"215","author":"P Yang","year":"2025","unstructured":"Yang P, Wang W, Liu Q, Mu S, Zha Y, Yan W, et al. Metabolic reprogramming of NK cells drives anti-tumor immunity. Crit Rev Oncol Hematol. 2025;215:104859.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1432_CR32","doi-asserted-by":"publisher","first-page":"11912","DOI":"10.1073\/pnas.0913422107","volume":"107","author":"P Sinai","year":"2010","unstructured":"Sinai P, Nguyen C, Schatzle JD, W\u00fclfing C. Transience in polarization of cytolytic effectors is required for efficient killing and controlled by Cdc42. Proc Natl Acad Sci USA. 2010;107:11912\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1432_CR33","doi-asserted-by":"publisher","first-page":"8842","DOI":"10.3390\/ijms23168842","volume":"23","author":"N Mosaddeghzadeh","year":"2022","unstructured":"Mosaddeghzadeh N, Pudewell S, Bazgir F, Kazemein Jasemi NS, Krumbach OHF, Gremer L, et al. CDC42-IQGAP interactions scrutinized: new Insights into the binding properties of the GAP-related domain. Int J Mol Sci. 2022;23:8842.","journal-title":"Int J Mol Sci"},{"key":"1432_CR34","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2001729","volume":"4","author":"LM Carlin","year":"2011","unstructured":"Carlin LM, Evans R, Milewicz H, Fernandes L, Matthews DR, Perani M, et al. A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse. Sci Signal. 2011;4:ra81.","journal-title":"Sci Signal"},{"key":"1432_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27081-1","volume":"8","author":"A L\u00f3pez Tob\u00f3n","year":"2018","unstructured":"L\u00f3pez Tob\u00f3n A, Suresh M, Jin J, Vitriolo A, Pietralla T, Tedford K, et al. The guanine nucleotide exchange factor Arhgef7\/\u03b2Pix promotes axon formation upstream of TC10. Sci Rep. 2018;8:8811.","journal-title":"Sci Rep"},{"key":"1432_CR36","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202317804","volume":"15","author":"I Melero","year":"2023","unstructured":"Melero I, Ochoa MC, Molina C, Sanchez-Gregorio S, Garasa S, Luri-Rey C, et al. Intratumoral coinjection of NK cells and NKG2A-neutralizing monoclonal antibodies. EMBO Mol Med. 2023;15:e17804.","journal-title":"EMBO Mol Med"},{"key":"1432_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1054-1","volume":"568","author":"M Hamieh","year":"2019","unstructured":"Hamieh M, Dobrin A, Cabriolu A, van der Stegen SJC, Giavridis T, Mansilla-Soto J, et al. CAR T-cell trogocytosis and cooperative killing regulate tumor antigen escape. Nature. 2019;568:112\u20136.","journal-title":"Nature"},{"key":"1432_CR38","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41375-020-0737-9","volume":"34","author":"M Kawashima","year":"2020","unstructured":"Kawashima M, Carreras J, Higuchi H, Kotaki R, Hoshina T, Okuyama K, et al. PD-L1\/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma. Leukemia. 2020;34:2405\u201317.","journal-title":"Leukemia"},{"key":"1432_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152864","volume":"132","author":"O Pagliano","year":"2022","unstructured":"Pagliano O, Morrison RM, Chauvin JM, Banerjee H, Davar D, Ding Q, et al. Tim-3 mediates T-cell trogocytosis to limit antitumor immunity. J Clin Investig. 2022;132:e152864.","journal-title":"J Clin Investig"},{"key":"1432_CR40","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.emboj.7601570","volume":"26","author":"J Caumartin","year":"2007","unstructured":"Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, et al. Trogocytosis-based generation of suppressive NK cells. EMBO J. 2007;26:1423\u201333.","journal-title":"EMBO J"},{"key":"1432_CR41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.semcancer.2021.12.006","volume":"86","author":"NA Kuburich","year":"2022","unstructured":"Kuburich NA, den Hollander P, Pietz JT, Mani SA. Vimentin and cytokeratin: good alone, bad together. Semin Cancer Biol. 2022;86:816\u201326.","journal-title":"Semin Cancer Biol"},{"key":"1432_CR42","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.4049\/jimmunol.0900821","volume":"183","author":"D Hudrisier","year":"2009","unstructured":"Hudrisier D, Clemenceau B, Balor S, Daubeuf S, Magdeleine E, Da\u00ebron M, et al. Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis. J Immunol. 2009;183:6102\u201313.","journal-title":"J Immunol"},{"key":"1432_CR43","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1073\/pnas.0800259105","volume":"105","author":"BJC Quah","year":"2008","unstructured":"Quah BJC, Barlow VP, McPhun V, Matthaei KI, Hulett MD, Parish CR. Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer. Proc Natl Acad Sci USA. 2008;105:4259\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1432_CR44","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-022-02003-x","volume":"28","author":"Y Li","year":"2022","unstructured":"Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, et al. KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med. 2022;28:2133\u201344.","journal-title":"Nat Med"},{"key":"1432_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00262-021-02982-9","volume":"71","author":"JL Thangaraj","year":"2022","unstructured":"Thangaraj JL, Phan MTT, Kweon S, Kim J, Lee JM, Hwang I, et al. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21. Cancer Immunol Immunother. 2022;71:613\u201325.","journal-title":"Cancer Immunol Immunother"},{"key":"1432_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0774-8","volume":"9","author":"L Zhao","year":"2018","unstructured":"Zhao L, Li R, Gan YH. Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT. Cell Death Dis. 2018;9:747.","journal-title":"Cell Death Dis"},{"key":"1432_CR47","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.3390\/cancers15153986","volume":"15","author":"C Zhou","year":"2023","unstructured":"Zhou C, Qiao C, Ji J, Xi W, Jiang J, Guo L, et al. Plasma exosome proteins ILK1 and CD14 correlated with organ-specific metastasis in advanced gastric cancer patients. Cancers. 2023;15:3986.","journal-title":"Cancers"},{"key":"1432_CR48","doi-asserted-by":"publisher","first-page":"e009560","DOI":"10.1136\/jitc-2024-009560","volume":"13","author":"M Wang","year":"2025","unstructured":"Wang M, Krueger JB, Gilkey AK, Stelljes EM, Kluesner MG, Pomeroy EJ, et al. Precision enhancement of CAR-NK cells through nonviral engineering and highly multiplexed base editing. J Immunother Cancer. 2025;13:e009560.","journal-title":"J Immunother Cancer"},{"key":"1432_CR49","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110\u201322.","journal-title":"Cell"},{"key":"1432_CR50","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1158\/0008-5472.CAN-11-3733","volume":"72","author":"ZC Fan","year":"2012","unstructured":"Fan ZC, Yan J, Liu GD, Tan XY, Weng XF, Wu WZ, et al. Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis. Cancer Res. 2012;72:2683\u201391.","journal-title":"Cancer Res"},{"key":"1432_CR51","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/cyto.a.21134","volume":"79","author":"Y Li","year":"2011","unstructured":"Li Y, Guo J, Wang C, Fan Z, Liu G, Wang C, et al. Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry. Cytom Part A J Int Soc Anal Cytol. 2011;79:848\u201354.","journal-title":"Cytom Part A J Int Soc Anal Cytol"},{"key":"1432_CR52","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/14653240802301872","volume":"10","author":"S Arai","year":"2008","unstructured":"Arai S, Meagher R, Swearingen M, Myint H, Rich E, Martinson J, et al. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Cytotherapy. 2008;10:625\u201332.","journal-title":"Cytotherapy"},{"key":"1432_CR53","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1021\/np100481m","volume":"73","author":"BD Hilton","year":"2010","unstructured":"Hilton BD, Martin GE. Investigation of the experimental limits of small-sample heteronuclear 2D NMR. J Nat Prod. 2010;73:1465\u20139.","journal-title":"J Nat Prod"},{"key":"1432_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ab.2009.09.001","volume":"396","author":"JP Ribeiro","year":"2010","unstructured":"Ribeiro JP, Palczewska M, Andr\u00e9 S, Ca\u00f1ada FJ, Gabius HJ, Jim\u00e9nez-Barbero J, et al. Diffusion nuclear magnetic resonance spectroscopy detects substoichiometric concentrations of small molecules in protein samples. Anal Biochem. 2010;396:117\u201323.","journal-title":"Anal Biochem"},{"key":"1432_CR55","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/onc.2015.293","volume":"35","author":"Z Meng","year":"2016","unstructured":"Meng Z, Jia LF, Gan YH. PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumor inhibition. Oncogene. 2016;35:2333\u201344.","journal-title":"Oncogene"},{"key":"1432_CR56","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan Y, Tao H, He J, Huang SY. The HDOCK server for integrated protein\u2012protein docking. Nat Protoc. 2020;15:1829\u201352.","journal-title":"Nat Protoc"},{"key":"1432_CR57","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s41592-022-01585-1","volume":"19","author":"C Zhang","year":"2022","unstructured":"Zhang C, Shine M, Pyle AM, Zhang Y. US-align: universal structure alignments of proteins, nucleic acids, and macromolecular complexes. Nat Methods. 2022;19:1109\u201315.","journal-title":"Nat Methods"},{"key":"1432_CR58","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s43018-020-00116-1","volume":"1","author":"JF Limzerwala","year":"2020","unstructured":"Limzerwala JF, Jeganathan KB, Kloeber JA, Davies BA, Zhang C, Sturmlechner I, et al. FoxM1 insufficiency hyperactivates Ect2-RhoA-mDia1 signaling to drive cancer. Nat Cancer. 2020;1:1010\u201324.","journal-title":"Nat Cancer"},{"key":"1432_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1593\/tlo.13367","volume":"6","author":"W Harb","year":"2013","unstructured":"Harb W, Fan A, Tran T, Danila DC, Keys D, Schwartz M, et al. Mutational analysis of circulating tumor cells using a novel microfluidic collection device and qPCR assay. Transl Oncol. 2013;6:528\u201338.","journal-title":"Transl Oncol"},{"key":"1432_CR60","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"1432_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-95360-9","volume":"15","author":"AA Mody","year":"2025","unstructured":"Mody AA, Mukthavaram R, Jiang P, Gangangari K, Pillarsetty N, Kesari PR, et al. Characterization of pritumumab in murine models and primate safety study. Sci Rep. 2025;15:10178.","journal-title":"Sci Rep"},{"key":"1432_CR62","doi-asserted-by":"publisher","first-page":"1009484","DOI":"10.3389\/fimmu.2022.1009484","volume":"13","author":"TAT Tran","year":"2023","unstructured":"Tran TAT, Kim YH, Duong THO, Thangaraj J, Chu TH, Jung S, et al. Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model. Front Immunol. 2023;13:1009484.","journal-title":"Front Immunol"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01432-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01432-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01432-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:02:21Z","timestamp":1782770541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01432-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":62,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01432-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7061678\/v1","asserted-by":"object"}]},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}